LATEST

• BUSINESS Sanofi Eyes Double-Digit Annual Growth for Japan Vaccine Business: Exec
  May 20, 2026

• REGULATORY Japan to Start CEA Technical Discussions as Early as May 25
  May 20, 2026

• REGULATORY LDP Study Group’s Honebuto Proposal Urges “Freeze” on On-Patent Drug Price Cuts
  May 20, 2026

• BUSINESS Takeda Hit with Massive Damages Verdict in US Amitiza Antitrust Case
  May 20, 2026

• BUSINESS Top Generic Makers Grow Sales on Higher Output, Shipment Recovery
  May 20, 2026

• BUSINESS Tapinarof Cream Logs Positive Data in Infant Atopic Dermatitis: Shionogi
  May 20, 2026

• BUSINESS Bayer Files FXIa Inhibitor Asundexian in Japan
  May 20, 2026

• REGULATORY PMDA Flags Iron Products, ST Combination Drug in Risk Review
  May 20, 2026

• REGULATORY MHLW Orders Detailed Report on Tavneos Efficacy Concerns
  May 20, 2026

• REGULATORY Japan Approves Jascayd, mNEXSPIKE, Zepbound OSA Use, Others
  May 19, 2026

• REGULATORY Japan to List 1st Biosimilars for Xolair, Ranmark, Simponi on May 20
  May 19, 2026

• BUSINESS Japan’s Big 4 Drug Wholesalers See Profit Pressure Intensify in FY2025
  May 19, 2026

• REGULATORY Japan Provides Stockpiled Avigan to UK for Hantavirus Prevention
  May 19, 2026

• REGULATORY 800 More Entities Seek War-Tied Supply Consultation as Future Anxiety Spreads
  May 19, 2026

• BUSINESS Asahi Kasei Starts Japan PIII of Extended Teribone Dosing
  May 19, 2026

• BUSINESS Allergan Files Botox Vista for Forehead Wrinkles
  May 19, 2026

• BUSINESS Stella Begins Japan PIII of BNCT for Recurrent Glioblastoma
  May 19, 2026

• BUSINESS Enhertu Earns 2 US Approvals in HER2-Positive Early Breast Cancer
  May 19, 2026

• REGULATORY Japan to Swiftly Consider Safety Measures over Tavneos: Minister
  May 19, 2026

• REGULATORY Japan Gives Orphan Tag to Revolution’s Pancreatic Cancer Drug, Others
  May 19, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »